Diagnosing metabolic syndrome in type 2 diabetic Turkish patients: comparison of AHA/NHLBI and IDF definitions

被引:0
|
作者
Basol, G. [1 ]
Barutcuoglu, B. [1 ]
Cakir, Y. [1 ]
Ozmen, B. [1 ]
Parildar, Z. [1 ]
Kose, T. [1 ]
Ozmen, D. [1 ]
Bayindir, O. [1 ]
机构
[1] Ege Univ, Fac Med, Dept Clin Biochem, TR-35100 Izmir, Turkey
关键词
type 2 diabetes mellitus; metabolic syndrome; prevalence; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; PROVISIONAL REPORT; III DEFINITIONS; RISK-FACTOR; ALL-CAUSE; PREVALENCE; MORTALITY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The objective of this study was to determine the percentage of metabolic syndrome (MetS) in a Turkish population with type 2 diabetes mellitus (T2DM) according to the American Heart Association/National Heart, Lung, and Blood Institute (AHA/NHLBI) and International Diabetes Federation (IDF) definitions and to assess the agreement among these definitions. Background: It is essential to identify the prevalence of MetS in diabetic patients, as MetS is a stronger risk factor for cardiovascular disease in patients with T2DM than in non-diabetic subjects. Methods: 235 consecutive patients with T2DM were included in the study. The MetS was defined according to AHA/NHLBI and IDF definitions. Cohen's kappa was used as a measure of agreement between the two definitions. Logistic regression analysis was performed to calculate the odds ratios. Results: The percentage of MetS was 85.1 % by AHA/NHLBI and 87.2 % by IDF criteria. The agreement between AHA/NHLBI and IDF was fairly good (kappa=0.55). Females were more affected than males. When the frequencies of each individual feature of the MetS according the definitions were assessed, hypertension was the most common feature in males, whilst abdominal obesity was in females. Serum triglyceride and waist circumference had the highest predictive ability for MetS according to AHA/NHLBI and IDF definitions, respectively. Conclusion: The MetS is a common condition among diabetic patients. Since diabetic patients carry a cluster of cardiovascular risk factors, correct identification of the MetS among this population is of great importance, for an integrated approach to reduce the high costs and the associated disabilities (Tab. 5, Fig. 2, Ref. 54). Full Text in free PDF www.bmj.sk.
引用
收藏
页码:253 / 259
页数:7
相关论文
共 50 条
  • [21] Evaluation of metabolic syndrome prognostic value in the identification of acute coronary syndrome by the different of Idf-Nhlbi/Aha-Ncep Atp III determinations
    Protopsaltis, I
    Kamaratos, A.
    Dragoumanos, V
    Konstantinou, G.
    Koutsovasilis, A.
    Anastasopoulos, D.
    Lepenos, T.
    Melidonis, A.
    SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 92S - 92S
  • [22] Metabolic syndrome in diabetic patients: impact of different definitions
    Habib, M. Hadj
    Lahmer, A.
    Kheira, T.
    Bendaoud, L.
    DIABETES & METABOLISM, 2012, 38 : A78 - A78
  • [23] Comparison of the NCEP ATP III and WHO definitions of the metabolic syndrome for predicting coronary artery calcification in asymptomatic type 2 diabetic patients
    Dhakshinamurthy, VA
    Lim, ET
    Lahiri, A
    Hopkins, D
    Lipkin, D
    CIRCULATION, 2005, 112 (17) : U792 - U792
  • [24] Metabolic syndrome in Type 2 diabetes: Comparison of WHO, modified ATPIII & IDF criteria
    Ahmed, Asma
    Khan, Talha Ehsan
    Yasmeen, Tahira
    Awan, Safia
    Islam, Najmul
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2012, 62 (06) : 569 - 574
  • [25] Metabolic syndrome and menopause in type 2 diabetic patients
    Zeryouh, N.
    Laalaoua, Y.
    Hamdane, C.
    Benyakhlef, S.
    Derbel, S.
    Rouf, S.
    Latrech, H.
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 186
  • [26] Hyperleptinemia and metabolic syndrome in type 2 diabetic patients
    Kim, SK
    Kim, HJ
    Hur, KY
    Ahn, CW
    Park, SW
    Cha, BS
    Cho, YW
    Lim, SK
    Kim, KR
    Lee, HC
    DIABETES, 2004, 53 : A349 - A349
  • [27] Prevalence of metabolic syndrome in Nepalese type 2 diabetic patients according to WHO, NCEP ATP III, IDF and Harmonized criteria
    Pokharel D.R.
    Khadka D.
    Sigdel M.
    Yadav N.K.
    Acharya S.
    Kafle R.C.
    Shukla P.S.
    Journal of Diabetes & Metabolic Disorders, 13 (1):
  • [28] Metabolic syndrome defined by IDF and AHA/NHLBI correlates better to carotid intima-media thickness than that defined by NCEP ATP III and WHO
    Ma, Wen-Ya
    Li, Hung-Yuan
    Hung, Chi Sheng
    Lin, Mao-Shin
    Chiu, Fu-Chun
    Lin, Cheng-Hsin
    Shih, Shyang-Rong
    Chuang, Lee-Ming
    Wei, Jung-Nan
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2009, 85 (03) : 335 - 341
  • [29] Prevalence of metabolic syndrome subgroups in type 2 diabetic patients
    Park, Mi-Kyoung
    Kim, Ja-Won
    Park, Ja Young
    Park, Soo Kyung
    Han, Young
    Lee, Hye-Jeong
    Kim, Duk Kyu
    DIABETES, 2007, 56 : A628 - A628
  • [30] Prevalence of the metabolic syndrome according to three definitions in patients with type 2 diabetes
    Morel, Lorraine Pelletier
    Radu, Alina
    Nejjar, Samia
    Slama, Gerard
    Larger, Etienne
    DIABETES, 2006, 55 : A533 - A533